Article
Plac1 is a tumor‐specific antigen capable of eliciting spontaneous antibody responses in human cancer patients
8 Jan 2008
Abstract excerpt
Immunoselection and tumor evasion constitutes one of the major obstacles in cancer immunotherapy. A potential solution to this problem is the development of polyvalent vaccines, and the identification of more tumor-specific antigens is a prerequisite for the development of cancer vaccines. To identify novel tumor-specific antigens, suppression subtractive hybridization (SSH) was performed to isolate genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
